Dorsey Wright & Associates Has $1.26 Million Stock Holdings in Ventas, Inc. $VTR

Dorsey Wright & Associates boosted its stake in Ventas, Inc. (NYSE:VTR) by 279.2% in the first quarter, Holdings Channel reports. The institutional investor owned 15,356 shares of the real estate investment trust’s stock after acquiring an additional 11,306 shares during the quarter. Dorsey Wright & Associates’ holdings in Ventas were worth $1,256,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. NewEdge Advisors LLC raised its holdings in shares of Ventas by 856.1% during the first quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock worth $545,000 after acquiring an additional 7,097 shares in the last quarter. Empowered Funds LLC grew its stake in Ventas by 6.8% in the first quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock valued at $576,000 after purchasing an additional 536 shares in the last quarter. Woodline Partners LP increased its position in Ventas by 46.8% in the 1st quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock worth $2,532,000 after purchasing an additional 11,739 shares during the last quarter. Focus Partners Wealth increased its position in Ventas by 130.4% in the 1st quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock worth $1,486,000 after purchasing an additional 12,233 shares during the last quarter. Finally, Gamco Investors INC. ET AL purchased a new stake in shares of Ventas during the 2nd quarter worth about $805,000. Institutional investors and hedge funds own 94.18% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on VTR shares. BMO Capital Markets reiterated an “outperform” rating and set a $100.00 price target on shares of Ventas in a report on Monday, May 4th. Evercore reaffirmed an “outperform” rating and set a $95.00 price objective on shares of Ventas in a research report on Wednesday, April 29th. Wells Fargo & Company raised their price objective on shares of Ventas from $93.00 to $96.00 and gave the company an “overweight” rating in a research report on Monday, June 1st. Weiss Ratings cut shares of Ventas from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Wednesday, July 8th. Finally, Royal Bank Of Canada boosted their target price on shares of Ventas from $91.00 to $98.00 and gave the stock an “outperform” rating in a research report on Monday, May 4th. Fourteen research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $96.17.

Ventas Trading Up 1.2%

Shares of VTR stock opened at $96.14 on Friday. The stock has a market cap of $46.74 billion, a price-to-earnings ratio of 174.81, a P/E/G ratio of 2.07 and a beta of 0.70. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25. Ventas, Inc. has a 52-week low of $65.15 and a 52-week high of $97.16. The firm has a fifty day moving average of $87.26 and a 200-day moving average of $84.16.

Ventas (NYSE:VTR) last released its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). The company had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. The firm’s revenue for the quarter was up 22.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.84 earnings per share. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. On average, equities research analysts forecast that Ventas, Inc. will post 3.88 earnings per share for the current fiscal year.

Ventas Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th were issued a dividend of $0.52 per share. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.2%. Ventas’s dividend payout ratio (DPR) is presently 378.18%.

Insiders Place Their Bets

In other news, Director Michael J. Embler bought 2,500 shares of Ventas stock in a transaction dated Wednesday, June 3rd. The shares were bought at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the purchase, the director owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. This trade represents a 14.97% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Walter C. Rakowich sold 1,152 shares of the company’s stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $90.20, for a total transaction of $103,910.40. Following the completion of the sale, the director directly owned 28,349 shares in the company, valued at approximately $2,557,079.80. The trade was a 3.90% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is currently owned by company insiders.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.